IBI3032

· Fortvita Biologics (USA)Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for IBI3032, covering 2025-09-17 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IBI3032 in Chinese Healthy Participants and Participants With Overweight or Obesity [Phase 1]